CRISPR Therapeutics (CRSP) Stock Has 51% Chance Of Rise In The Next One Month 2023-01-07 . Show More... Peer Comparison Name Last Updated CRISPR Therapeutics vs. Coherus BioSciences: With Return Forecast Of 49%, CRISPR Therapeutics Is A Better Bet 2024-12-22 CRISPR Therapeutics vs. Editas...